About the Director

Dr. Richard Goldberg.  Head and shoulders shot.Richard M Goldberg, MD, is West Virginia University Cancer Institute’s (WVUCI) Director, and Director of the WVU Cancer Signature Program. He serves as a member of WVU health sciences Vice President and Executive Dean, Clay Marsh’s leadership team.  As WVUCI’s Director, he oversees the clinical, research, and teaching missions of the cancer institute and its component organizations that include satellite clinical and clinical research locations that are dispersed throughout West Virginia.

Considered an international leader in gastrointestinal cancer treatment and research as well as in leadership of cancer programs in academic medicine, Dr. Goldberg has been a principal investigator, co-PI, co-investigator and mentor on multiple research and training grants funded through the National Cancer Institute (NCI). He has published more than 320 papers in peer-reviewed journals. His clinical interests are in management of patients with malignancies in the gastrointestinal tract, particularly colorectal and neuroendocrine cancers. His research focuses on defining new treatments, elucidating inherited cancer susceptibility, and the identification of predictive and prognostic factors in GI cancers. He helps to lead the Alliance for Clinical Trials in Oncology as the Associate Group Chair of this NCI funded organization that is a member of the National Clinical Trials Network. The Alliance conducts clinical trials and does translational research across the US and Canada.

He is a sought after lecturer at academic centers and scientific conferences across the nation and the world. He has mentored many MD, MD/PhD, and PhD doctoral students, post-doctoral researchers, and junior faculty over his 33 years as a medical oncologist in academic settings.

He is a graduate of Harvard University, earning an undergraduate degree cum laude in biology in 1975 and received his medical degree from the State University of New York Upstate Medical University in 1989 where he was elected to the Alpha Omega Alpha honor medical society.

Prior to his arrival at WVU in 2017, he served as a physician in chief of the both the James Cancer Hospital at The Ohio State University (OSU) and, prior to that of the North Carolina Cancer Hospital at the University of North Carolina in Chapel Hill (UNC). He was an Associate Director at both the OSU the UNC Comprehensive Cancer Centers and the Division Chief of Hematology and Oncology at UNC and Acting Division Director of Medical Oncology at OSU. Prior to that, he was a consultant at the Mayo Clinic in Rochester and Associate Chair of the Department of Medicine at the Geisinger Clinic in Danville, PA.  

Dr. Goldberg serves on several national scientific advisory committees and on the scientific advisory committee for a number of pharmaceutical companies at the corporate level. He is a Fellow in the American College of Physicians and the American Society of Clinical Oncology. He is married to Lynda Goldberg MBA, MPH and has two adult children.